Catapult Therapy TCR | Evaluate

October 13, 2016

Adaptimmune puts fludarabine back on the agenda

First human Crispr trial is a go, but don’t ask about the IP

April 17, 2016

AACR – Mage-A3 double-whammy hits Kite

April 14, 2016

Interview – UK cell therapy minnow squares up to Juno